The Use of ATMPs in Oncology Clinical Trials
How can phase I studies with ATMPs address unmet needs in oncology and what are the challenges? In this episode of Conversations in Drug Development, Dr Katherine Bowen is joined by Pharmaceutical Phy...
21 Maj 202419min
How are GMO Regulations Impacting Clinical Development in Europe?
In this episode of Conversations in Drug Development, our host Harriet Edwards, is joined by Director of Regulatory Affairs, Dr Sabine Ruehle, to discuss the challenges of navigating genetically modif...
25 Apr 202424min
US Drug Development: The Latest Regulatory Trends and Initiatives
In this episode of Conversations in Drug Development, host Dr Harriet Edwards is joined by Katy Rudnick and Dr Julie Warner from Boyds to discuss US regulatory trends and initiatives at the FDA. This ...
19 Mars 202422min
The Regulatory Challenges of Rare Disease Drug Development
To celebrate Rare Disease Day, we are back with another Conversation in Drug Development, this time discussing the unique challenges of rare disease drug development. Dr Eric Hardter, Associate Direct...
28 Feb 202429min
The Drug Development Landscape: Trends and Predictions for 2024
We are kickstarting 2024 with a Conversation in Drug Development with CEO and Founder of Boyds, Professor Alan Boyd. In this podcast episode, our host Harriet Edwards, and Professor Alan Boyd discuss ...
22 Jan 202425min
Off-the-Shelf Cell Therapies: Breaking Barriers and Revolutionizing Patient Care
In this episode of "Conversations in Drug Development", Harriet Edwards and Dr. Patrick Ginty discuss off-the-shelf cell therapies, explaining how these therapies are manufactured and their ability to...
4 Dec 202320min
The Future of Drug Development: AI’s Role in Revolutionizing the Industry
In this episode of Conversations in Drug Development, Dr. Julie Warner and Harriet Edwards discuss the revolutionizing role of artificial intelligence (AI) in drug development, exploring its applicati...
8 Nov 202322min
Recent Trends in Oncology Drug Development
In this episode, Dr Katherine Bowen and Dr Julie Warner delve deep into the ever-evolving world of oncology drug development and the regulatory landscape in the US and EU. Join us in this conversation...
4 Okt 202325min
